Therapeutic Potential of Liuwei Dihuang Pill Against KDM7A and Wnt/β-catenin Signaling Pathway in Diabetic Nephropathy-related Osteoporosis

Overview

Journal Biosci Rep

Specialty Cell Biology

Date 2020 Sep 11

PMID 32914833

Citations 17

Authors

Ming Ming Liu

Rui Dong

Zhen Hua

Nan Ning Lv

Yong Ma

Gui Cheng Huang

Jian Cheng

Hai Yan Xu

Affiliations

Soon will be listed here.

Abstract

The effects of Liuwei Dihuang pill (LWDH) on diabetic nephropathy-related osteoporosis (DNOP) are unclear. The present study aimed to evaluate the effects of LWDH on KDM7A and Wnt/β-catenin signaling pathway in DNOP rats and the high glucose-induced MC3T3-E1 cells. A DNOP model was prepared by streptozotocin in 9-week-old male Sprague-Dawley (SD) rats to evaluate the effects of LWDH. The cell viability and differentiation capacity of high glucose-induced MC3T3-E1 cells were determined by CCK-8 assay, Alizarin Red staining, and alkaline phosphatase (ALP) staining, respectively. Furthermore, the expressions of KDM7A and Wnt1/β-catenin pathway-related proteins were determined by Western blot analysis. Treatment of DNOP rats with LWDH could significantly ameliorate the general state, degradation of renal function, and renal pathological changes. LWDH decreased the levels of TNF-α, IL-6, IL-8, IL-1β, ALP, and TRAP, and increased the calcium, phosphorus in serum, as well as decreased the level of the calcium and phosphorus in the urine. Besides, LWDH significantly improved bone mineral density (BMD), bone volume (BV), and the bone microstructure of DNOP rats. Moreover, LWDH increased the levels of the elastic modulus, ultimate load, and bending strength in the femurs. In MC3T3-E1 cells, serum-containing LWDH significantly increases in cell viability and osteoblastic differentiation capability. The expression of α-SMA, vimentin, KDM7A, Wnt1 and β-catenin were significantly down-regulated, and the E-cadherin, H3K9-Me2, H3K27-Me2, BMP-4, BMP-7, Runx2, osteocalcin, and Col1a1 were significantly up-regulated with LWDH treatment. The present study shows that LWDH has a therapeutic effect on DNOP, in part, through down-regulation of KDM7A and Wnt/β-catenin pathway.

Citing Articles

Risk factors for developing osteoporosis in diabetic kidney disease and its correlation with calcium-phosphorus metabolism, FGF23, and Klotho.

Yang F, Wu Y, Zhang W World J Diabetes. 2025; 16(1):98714.

PMID: 39817221 PMC: 11718466. DOI: 10.4239/wjd.v16.i1.98714.

Qianggu concentrate: unlocking bone protection power via antioxidative SIRT1/NRF2/HO-1 pathways in type 2 diabetic osteoporosis.

Wang K, Dang X, Wang Y, Yang Q, Zhang T, Yang P Front Pharmacol. 2024; 15:1426767.

PMID: 39175549 PMC: 11338786. DOI: 10.3389/fphar.2024.1426767.

Chromium Picolinate Regulates Bone Metabolism and Prevents Bone Loss in Diabetic Rats.

Zheng H, Yan W, Shao M, Qi S Molecules. 2024; 29(5).

PMID: 38474436 PMC: 10935143. DOI: 10.3390/molecules29050924.

: a potential herb for treatment of osteoporosis.

Tang X, Huang Y, Fang X, Tong X, Yu Q, Zheng W Front Med (Lausanne). 2023; 10:1289144.

PMID: 38111697 PMC: 10725965. DOI: 10.3389/fmed.2023.1289144.

Exploring Effects and Mechanism of Ingredients of Herba Epimedii on Osteogenesis and Osteoclastogenesis .

Song L, Zhou Y, Qu L, Wang D, Diao X, Zhang X Comb Chem High Throughput Screen. 2023; 27(19):2824-2837.

PMID: 37957850 DOI: 10.2174/0113862073243559231023065934.

References

Kim B, Lee S, Song S, Kim W, Song E, Lee J . Protective Effects of Melon Extracts on Bone Strength, Mineralization, and Metabolism in Rats with Ovariectomy-Induced Osteoporosis. Antioxidants (Basel). 2019; 8(8). PMC: 6720457. DOI: 10.3390/antiox8080306. View

An Y, Zhang H, Wang C, Jiao F, Xu H, Wang X . Activation of ROS/MAPKs/NF-κB/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis. FASEB J. 2019; 33(11):12515-12527. PMC: 6902677. DOI: 10.1096/fj.201802805RR. View

Ge J, Xie L, Chen J, Li S, Xu H, Lai Y . Liuwei Dihuang Pill () Treats Postmenopausal Osteoporosis with Shen (Kidney) Yin Deficiency via Janus Kinase/Signal Transducer and Activator of Transcription Signal Pathway by Up-regulating Cardiotrophin-Like Cytokine Factor 1 Expression. Chin J Integr Med. 2016; 24(6):415-422. DOI: 10.1007/s11655-016-2744-2. View

Guo C, Xie J, Hong R, Pan H, Zhang F, Liang Y . Puerarin alleviates streptozotocin (STZ)-induced osteoporosis in rats through suppressing inflammation and apoptosis via HDAC1/HDAC3 signaling. Biomed Pharmacother. 2019; 115:108570. DOI: 10.1016/j.biopha.2019.01.031. View

Xia B, Xu B, Sun Y, Xiao L, Pan J, Jin H . The effects of Liuwei Dihuang on canonical Wnt/β-catenin signaling pathway in osteoporosis. J Ethnopharmacol. 2014; 153(1):133-41. DOI: 10.1016/j.jep.2014.01.040. View

AL B Vasanth Rao V, Tan S, Candasamy M, Bhattamisra S . Diabetic nephropathy: An update on pathogenesis and drug development. Diabetes Metab Syndr. 2019; 13(1):754-762. DOI: 10.1016/j.dsx.2018.11.054. View

Tian T, Chen H, Zhao Y . Traditional uses, phytochemistry, pharmacology, toxicology and quality control of Alisma orientale (Sam.) Juzep: a review. J Ethnopharmacol. 2014; 158 Pt A:373-87. DOI: 10.1016/j.jep.2014.10.061. View

Zheng H, Qi S, Chen C . Salidroside Improves Bone Histomorphology and Prevents Bone Loss in Ovariectomized Diabetic Rats by Upregulating the OPG/RANKL Ratio. Molecules. 2018; 23(9). PMC: 6225177. DOI: 10.3390/molecules23092398. View

Liu C, Wang L, Zhu R, Liu H, Ma R, Chen B . Rehmanniae Radix Preparata suppresses bone loss and increases bone strength through interfering with canonical Wnt/β-catenin signaling pathway in OVX rats. Osteoporos Int. 2018; 30(2):491-505. DOI: 10.1007/s00198-018-4670-y. View

10.

Huang C, Xiang Y, Wang Y, Li X, Xu L, Zhu Z . Dual-specificity histone demethylase KIAA1718 (KDM7A) regulates neural differentiation through FGF4. Cell Res. 2010; 20(2):154-65. DOI: 10.1038/cr.2010.5. View

11.

Avioli L . Calcium and osteoporosis. Annu Rev Nutr. 1984; 4:471-91. DOI: 10.1146/annurev.nu.04.070184.002351. View

12.

Zhu L, Han J, Yuan R, Xue L, Pang W . Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway. Biol Res. 2018; 51(1):9. PMC: 5878418. DOI: 10.1186/s40659-018-0157-8. View

13.

Vestergaard P . Bone metabolism in type 2 diabetes and role of thiazolidinediones. Curr Opin Endocrinol Diabetes Obes. 2009; 16(2):125-31. DOI: 10.1097/MED.0b013e328325d155. View

14.

Cheng P, Chen Y, Cheng W, Lu P, Chen H, Chen B . Wnt Signaling Regulates Blood Pressure by Downregulating a GSK-3β-Mediated Pathway to Enhance Insulin Signaling in the Central Nervous System. Diabetes. 2015; 64(10):3413-24. DOI: 10.2337/db14-1439. View

15.

Rossini M, Gatti D, Adami S . Involvement of WNT/β-catenin signaling in the treatment of osteoporosis. Calcif Tissue Int. 2013; 93(2):121-32. DOI: 10.1007/s00223-013-9749-z. View

16.

Guariguata L, Whiting D, Hambleton I, Beagley J, Linnenkamp U, Shaw J . Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014; 103(2):137-49. DOI: 10.1016/j.diabres.2013.11.002. View

17.

Lu H, Kraut D, Gerstenfeld L, Graves D . Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. Endocrinology. 2002; 144(1):346-52. DOI: 10.1210/en.2002-220072. View

18.

Gaur T, Lengner C, Hovhannisyan H, Bhat R, Bodine P, Komm B . Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem. 2005; 280(39):33132-40. DOI: 10.1074/jbc.M500608200. View

19.

Cheng J, Xu H, Liu M, Cai J, Wang L, Hua Z . Catalpol Promotes the Proliferation and Differentiation of Osteoblasts Induced by High Glucose by Inhibiting KDM7A. Diabetes Metab Syndr Obes. 2020; 13:705-712. PMC: 7081648. DOI: 10.2147/DMSO.S246433. View

20.

Liu T, Xiang Z, Chen F, Yin D, Huang Y, Xu J . Theabrownin suppresses in vitro osteoclastogenesis and prevents bone loss in ovariectomized rats. Biomed Pharmacother. 2018; 106:1339-1347. DOI: 10.1016/j.biopha.2018.07.103. View